Mylan - Positive Investment Alert
Mylan stock price has corrected about 20% soon after announcing that it intends to buy Europe based specialty pharma company - Meda. The price offered is a 90% premium to Meda's last traded price.
from Biotech News
Mylan stock price has corrected about 20% soon after announcing that it intends to buy Europe based specialty pharma company - Meda. The price offered is a 90% premium to Meda's last traded price.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments